16 Jul 2018

TOP U.K. SURGEON CALLS FOR NEW PROCEDURES TO UNDERGO CLINICAL TRIALS IN ENGLAND

  Prof Derek Alderson, MD and the president of the Royal College of Surgeons, said the benefits of surgical innovations in the United Kingdom must “absolutely, unequivocally” be backed by evidence, either through randomised controlled trials or official registries designed to track patient outcomes. The move would bring surgical innovation

0
16 Jul 2018

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions

0
16 Jul 2018

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

Med-Aesthetic Solutions Inc., the developer and manufacturer of the proprietary SaltFacial skin renewal system, has formed a partnership with Aesthetic Management Partners to represent its product line exclusively, in select markets worldwide. The partnership commenced with a strong presence at The Aesthetic Show in Las Vegas in July. Aesthetic Management

0
08 Jul 2018

GLOBAL CVC MARKET TO GROW AT 3.9%

  The “Global Central Venous Catheters (CVCs) Market 2017-2021” report has been added to Research and Markets’ offering. The CVCs market is expected to grow at a CAGR of 3.94 percent during the period 2017-2021. The report has been prepared based on an in-depth market analysis with inputs from industry

0
26 Jun 2018

DERMAKA HAS NEW ENHANCED NATURAL HEALING FORMULA

  Dermaka cream is an all-natural plant-based product that aids in skin healing, rejuvenation, and substantially reduces redness and bruising. Dermaka cream was developed by Ronald Bush, MD, FACS, to minimize bruising and inflammatory responses of the skin in the post-operative period. While the product has been around for several

0
26 Jun 2018

THE MARKETING BOT: HOW TO USE YOUR TIRELESS, HIGH-ROI MARKETING GENIUS

By Scott Harvey It’s been said, and it’s pretty well-accepted, that e-mail is the “killer app” that turned the Internet from an interesting technology into the behemoth it has become. There’s no question that email, and its offspring such as various messaging apps such as Facebook Messenger and WhatsApp, have

0
26 Jun 2018

VENA CAVA FILTERS TO SEE DOUBLE-DIGIT CAGR ANNUAL GROWTH

The global inferior vena cava filters (IVCFs)market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the period 2018-2022, according to a new 126-page market research study (SKU: IRTNTR21662) published early this year by Technavio. A free sample report or the full

0
24 Jun 2018

INTACT VASCULAR OFFERS TOBA BTK DATA

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has praised the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting

0
24 Jun 2018

AMERICAN VEIN AIDS HEALTH4HAITI BY DONATING 50 SETS OF SCRUBS

American Vein & Vascular Institute recently donated more than 50 sets of scrubs to Health4Haiti, a non-profit that improves lives and healthcare outcomes for the citizens of Gonaives, Haiti. Gonaives is currently served by one public hospital, according to Health4Haiti’s website (healthfourhaiti.com), and that hospital has been destroyed twice due

0
21 Jun 2018

MOST VENOUS DISEASE CAN BE CLASSIFIED AS COSMETIC

      By Ronald Bush, MD, FACS In 1992, I left a busy practice of thoracic and vascular surgery and began the in-office treatment of varicose veins. At that time, high ligation and stripping using tumescent with ultra sound guided assistance was our treatment of choice for saphenous insufficiency.

0